In a trio of lung cancer asbestos cases, a New York appellate court has reversed the trial court and granted dismissal to a floor-tile manufacturer because the plaintiffs were unable to show sufficient specific causation.

The opinions from the state appellate court in Manhattan were handed down on the same day it tossed out a $120 million award against Johnson & Johnson in a suit in which plaintiffs linked talcum powder use to lung cancer.